REVOLUTION PRO™

Early Cancer Detection Starts Here.

More Signal. Earlier Detection. Better Outcomes.

Analyte extraction defines what can be detected.

Revolution Pro brings nRichDX high-recovery liquid biopsy sample preparation into an automated workflow designed to support low-abundance molecular applications, flexible sample inputs, and scalable laboratory operation.

80%–95% extraction efficiency Up to 24 samples per batch cfDNA, cfRNA, cfTNA & CTCs
nRichDX Revolution Pro automated sample preparation system nRichDX nRicher Cartridge
FLAGSHIP SYSTEM Automated recovery-focused sample preparation
SINGLE EXTRACTION 1 mL–100 mL*
01 80%–95% Extraction Efficiency
02 1–100 mL Single-Extraction Range*
03 24 Samples per Batch
04 ~2 Hours Processing Time

* Up to 50 mL for cell-free applications.

THE UPSTREAM CONSTRAINT

Early-Stage Cancer Detection Remains the Challenge.

Published validation studies from leading multi-cancer early detection companies evidence the difficulty in detecting cancer at its earliest stage.

The most overlooked constraint in liquid biopsy is not sequencing or bioinformatics. It is the amount of analyte entering the assay.

THE CONSEQUENCE The circulating biomarkers needed to improve sensitivity never reached the assay.
STUDY-REPORTED CANCER DETECTION SENSITIVITY Stage I / Stage II / Stage I–II
Study-reported cancer detection sensitivity for three multi-cancer early detection companies
Sources 1 Klein EA et al., Ann Oncol. 2021;32:1167–1177.   2 Gainullin VG et al., AACR 2026, Abstract 1108.   3 Gittelman R et al., AACR 2025, Abstract 6425.
THE SENSITIVITY LADDER™

Find the Optimal Sample Input.

Know the optimal sample input that maximizes your assay’s clinical sensitivity.

Empirically determine the optimal plasma volume for Stage I & II early cancer and MRD detection.

Evaluate assay performance across increasing sample volumes to identify where sensitivity plateaus and establish the sample input that best supports assay performance.

BUILD THE LADDER. Find the plateau. Maximize the sensitivity.
Sensitivity Ladder illustration showing assay sensitivity across increasing sample input volumes
Example for illustration purposes only. Reliable detection of rare circulating biomarkers becomes increasingly challenging when input material is limited.1
THE UPSTREAM QUESTIONS
How much analyte material is needed to achieve reliable Stage I detection? How much usable molecular information reaches the assay?
WHY IT MATTERS

Low-abundance detection starts upstream.

Low-Abundance Detection

Early cancer and MRD detection is an input problem.

More Recovery Opportunity

Rare molecular signals need more opportunities to be recovered before detection begins.

Stronger Assay Starting Point

More recovered analyte positions downstream assays for earlier detection.

WHAT YOU'LL LEARN

Make sample input a measured variable.

If assay sensitivity improves with increased sample input.
Sample volume that increases sensitivity without reducing specificity.
Optimal balance between sample input and assay performance.
If higher sample input reduces sequencing or bioinformatics costs.
Clinical justification for larger sample collection.
FIND THE OPTIMAL SAMPLE INPUT

Evaluate. Measure. Optimize. Standardize. Automate.

Use the same framework to move from sample-input evaluation into a standardized automated workflow.

01
Evaluate

Use Revolution Pro to test multiple sample inputs.

02
Measure

Quantify clinical sensitivity at each input volume.

04
Standardize

Select the lowest input delivering maximum clinical performance.

05
Automate

Use Revolution Pro to perform single, fully automated extractions for volumes up to 50 mL.

1 Deveson IW, et al. Nat Biotechnol. 2021;39:1115–1128. doi:10.1038/s41587-021-00857-z.

FROM ASSAY DEVELOPMENT TO COMMERCIAL DEPLOYMENT

The Sensitivity Ladder™ is an Exclusive nRichDX Capability.

Revolution Pro enables developers to determine the sample input volume that delivers maximum assay sensitivity and then transition that optimized workflow into routine, high-throughput production.

THE DIFFERENCE Optimize for assay performance rather than for the limitations of extraction technology.
No other extraction platform combines:
01
High extraction yields, 80%–95%

Ensure optimization identifies the lowest sample volume capable of achieving maximum assay sensitivity.

02
Single-pass processing

From 1 mL to 100 mL, eliminating the variability and data erosion associated with multiple extractions and pooled eluates.

03
Linear analyte recovery

Across the full sample volume range, providing accurate, unbiased sensitivity comparisons without data distortion.

04
Broad analyte compatibility

Including cfDNA, cfRNA, cfTNA, and circulating tumor cells.

05
Broad sample compatibility

Including whole blood, plasma, urine, cerebrospinal fluid, peritoneal fluid, and other clinically relevant body fluids.

06
A fully automated, high-throughput workflow

Move the optimized extraction protocol from assay development into scalable clinical or commercial production using the same extraction platform.

FROM ASSAY DEVELOPMENT TO COMMERCIAL DEPLOYMENT

Find the input. Standardize the workflow. Automate the process.

The Sensitivity Ladder™ enables assay developers to determine the sample input volume that delivers maximum assay sensitivity. Revolution Pro then carries that optimized extraction workflow into routine, high-throughput production.

01 Develop

Evaluate multiple sample inputs using Revolution Pro.

02 Optimize

Identify where assay performance plateaus.

04 Automate

Move the optimized extraction protocol into routine automated processing.

ONE PATH TO SCALE The same recovery platform can support assay development, workflow standardization, and scalable production.
SHARED RECOVERY FOUNDATION

One Recovery Foundation. Benefits at Every Scale.

Two automation configurations deliver the same core advantages for assay development, routine processing, and high-throughput liquid biopsy workflows.

01
Sample Type Flexibility

Blood, plasma, urine, CSF, peritoneal fluid, and other biofluids.

02
Broad Analyte Compatibility

cfDNA, cfRNA, cfTNA, and CTC workflows.

nRichDX nRicher Cartridge nRicher Cartridge The patented heart of the Revolution platform.
03
80%–95% Recovery

Unmatched extraction/enrichment efficiency for higher yields across the supported sample volume range.

04
1 mL–100 mL

The widest sample volume range in a single extraction.*

* Up to 50 mL for cell-free applications.

CHOOSE THE RIGHT PATH TO AUTOMATION

Scalable automation designed around the workflow.

Evaluate the configuration and throughput requirements that best support your assay and laboratory workflow.

AUTOMATEDResearch Use Only
nRichDX Revolution Pro + Hamilton STAR automation platform

Revolution Pro + Hamilton

Scalable automation designed to support high-throughput batch processing.

WorkflowAutomated extraction with interface to Hamilton STAR for wash/elution.
AutomationAutomated
Designed ForHigh-throughput batch processing
FULLY AUTOMATEDIVD
nRichDX Revolution Pro ES integrated automation system

Revolution Pro/ES

Integrated automation designed to minimize operator intervention from sample preparation through purified analyte.

WorkflowFully automated sample-to-elution with Revolution ES module.
AutomationFully Automated
Designed ForSample preparation through purified analyte
FROM RECOVERY TO ROUTINE OPERATION

Automation that carries the optimized workflow forward.

Revolution Pro is designed to reduce hands-on burden while supporting mixed sample inputs, high-throughput reagent capacity, and continuity across the laboratory workflow.

01 10 Minutes Hands-on time per batch
02 120 Samples Throughput per shift
03 480 Extractions Supported by the reagent kit
04 Mixed Inputs Multiple sample volumes and sample types in the same batch
Semi-Random Access Sample loading designed for uninterrupted workflow.
Never-Dry System™ Dual reagent system designed for continuous operation.
Programmed Application Modes Programmed modes within the Revolution Pro workflow.
BUILT FOR LOW-ABUNDANCE MOLECULAR APPLICATIONS

When the target is scarce, the starting material matters.

Revolution Pro is designed around workflows where the quantity and quality of molecular input can constrain downstream analysis.

03
MOLECULAR MONITORING

Therapy Monitoring & Molecular Profiling

Support broad analyte workflows across cfDNA, cfRNA, cfTNA, and circulating tumor cells.

04
RESEARCH TRANSLATION

Translational Research

Standardize recovery-focused sample preparation across variable sample types, volumes, and automation requirements.

What enters the assay defines what can be detected. Better upstream recovery preserves more opportunity for downstream analysis.
ONE SYSTEM VIEW Recovery. Compatibility. Operational Performance. Workflow Continuity.

From single-pass sample handling through automated throughput, the specifications below define the operating range of Revolution Pro.

REVOLUTION PRO FEATURES

Flagship performance, defined.

Complete system specifications from sample input through throughput, workflow flexibility, and continuous operation.

nRichDX Revolution Pro
Extraction Efficiency80%–95%
Samples per Batch24
Throughput per Shift120
Hands-On Time10 min
PRODUCT SPECIFICATION MATRIXRevolution Pro
Single system view
01Recovery & Sample Handling
AutomationFully automated sample-to-elution with Revolution ES module
Optional AutomationFully automated extraction with interface to Hamilton STAR for wash/elution
Extraction Efficiency80%–95%
Sample Volumes (single extraction)1 mL–100 mLUp to 50 mL for cell-free applications
Elution Options25 µL to 100 µL across the sample volume range
02Compatibility
AnalytescfDNA, cfRNA, cfTNA, CTCs
Sample TypesPlasma, Cell-free Urine, Whole Urine, Whole Blood, CSF, Peritoneal Fluid, Other Body Fluids
Samples per Batch24
Sample FlexibilityExtract from multiple sample volumes and multiple sample types in same batch
03Operational Performance
Processing Time~2 hours
Hands-On Time10 minutes per batch
Throughput per Shift120 samples
High-Throughput SupportReagent kit supports up to 480 extractions
04Workflow Continuity
Workflow EfficiencySemi-random access sample loading for uninterrupted workflow
Never-Dry System™Dual reagent system ensures continuous operation
Application ModesProgrammed application modes
BROAD MOLECULAR COMPATIBILITY

One platform. Multiple molecular inputs.

Revolution Pro supports liquid biopsy workflows across multiple analytes and biologically relevant sample types.

SUPPORTED SAMPLE TYPES
PlasmaCell-free UrineWhole UrineWhole BloodCSFPeritoneal FluidOther Body Fluids
SCIENTIFIC & TECHNICAL RESOURCES

Go deeper into the recovery science.

Explore supporting publications, posters, technical resources, and the full Sensitivity Ladder™ framework behind nRichDX liquid biopsy sample preparation.

READY TO OPTIMIZE YOUR ASSAY PERFORMANCE?

Evaluate the input. Find the plateau. Automate the workflow.

Use The Sensitivity Ladder™ to evaluate multiple sample inputs and translate the optimized extraction workflow into Revolution Pro.

Schedule a live Revolution Pro demonstration. Evaluate multiple sample inputs using The Sensitivity Ladder™. Discover the optimal plasma input for maximum assay sensitivity.